Natixis Advisors, L.P. Dexcom Inc Transaction History

Natixis Advisors, L.P.

$53.5 Billion
Q4 2024

A detailed history of Natixis Advisors, L.P. transactions in Dexcom Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 193,532 shares of DXCM stock, worth $17.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

193,532

Previous 35,408 446.58%

Holding current value

$17.5 Million

Previous $2.37 Million 534.26%

% of portfolio

0.03%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$65.68 - $81.01 $10.4 Million - $12.8 Million	158,124 Added 446.58%	193,532 $15.1 Million
Q3 2024 Nov 06, 2024	SELL	$64.0 - $116.06 $67.6 Million - $123 Million	-1,056,986 Reduced 96.76%	35,408 $2.37 Million
Q2 2024 Aug 01, 2024	SELL	$110.31 - $140.45 $7.02 Million - $8.93 Million	-63,606 Reduced 5.5%	1,092,394 $124 Million
Q1 2024 Apr 25, 2024	BUY	$114.22 - $140.1 $3.02 Million - $3.7 Million	26,430 Added 2.34%	1,156,000 $160 Million
Q4 2023 Feb 06, 2024	BUY	$75.49 - $124.16 $49.9 Million - $82.1 Million	661,584 Added 141.37%	1,129,570 $140 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $35.6 Million - $57 Million	413,407 Added 757.45%	467,986 $43.7 Million
Q2 2023 Aug 15, 2023	BUY	$112.47 - $130.98 $258,118 - $300,599	2,295 Added 4.39%	54,579 $7.01 Million
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $1.22 Million - $1.44 Million	11,683 Added 28.78%	52,284 $6.07 Million
Q4 2022 Jan 27, 2023	BUY	$84.98 - $122.67 $572,425 - $826,305	6,736 Added 19.89%	40,601 $4.6 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $233,172 - $287,625	-3,054 Reduced 8.27%	33,865 $2.73 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $2.51 Million - $4.91 Million	36,919 New	36,919 $2.75 Million

Others Institutions Holding DXCM

# of Institutions

1,078

Shares Held

351M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $35B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Dexcom Inc Transaction History